Haemolytic disease of the fetus and newborn
Top Cited Papers
- 20 April 2015
- journal article
- review article
- Published by Wiley in Vox Sanguinis
- Vol. 109 (2), 99-113
- https://doi.org/10.1111/vox.12265
Abstract
Haemolytic Disease of the Fetus and Newborn (HDFN) is caused by maternal alloimmunization against red blood cell antigens. In severe cases, HDFN may lead to fetal anaemia with a risk for fetal death and to severe forms of neonatal hyperbilirubinaemia with a risk for kernicterus. Most severe cases are caused by anti-D, despite the introduction of antental and postnatal anti-D immunoglobulin prophylaxis. In general, red blood cell antibody screening programmes are aimed to detect maternal alloimmunization early in pregnancy to facilitate the identification of high-risk cases to timely start antenatal and postnatal treatment. In this review, an overview of the clinical relevance of red cell alloantibodies in relation to occurrence of HDFN and recent views on prevention, screening and treatment options of HDFN are provided.Keywords
This publication has 91 references indexed in Scilit:
- Costs and Clinical Outcomes of Noninvasive Fetal RhD Typing for Targeted ProphylaxisObstetrics & Gynecology, 2013
- Routine Antenatal Anti-D Prophylaxis in Women Who Are Rh(D) Negative: Meta-Analyses Adjusted for Differences in Study Design and QualityPLOS ONE, 2012
- Cell‐free fetal DNA in specimen from pregnant women is stable up to 5 daysPrenatal Diagnosis, 2011
- Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn—a prospective randomized controlled trialEuropean Journal of Pediatrics, 2010
- Risk factors for RhD immunisation despite antenatal and postnatal anti‐D prophylaxisBJOG: An International Journal of Obstetrics and Gynaecology, 2009
- Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008Transfusion Medicine and Hemotherapy, 2009
- Women's attitude towards prenatal screening for red blood cell antibodies, other than RhDBMC Pregnancy and Childbirth, 2008
- Is fetal RHD typing in all RhD negative women cost effective?BMJ, 2008
- Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility studyBMJ, 2008
- RED CELL ANTIBODIES DETECTED IN ANTENATAL TESTS ON RHESUS POSITIVE WOMEN IN SOUTH AND MID WALES, 1948–1978BJOG: An International Journal of Obstetrics and Gynaecology, 1981